Liposomal Eribulin Mesylate

Known as: E7389 Liposomal Formulation, E7389-LF 
A liposome-encapsulated formulation of the mesylate salt form of eribulin, a synthetic, macrocyclic ketone analogue of halichondrin B, a substance… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2013
012320092013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Eribulin mesylate (E7389), a tubulin and microtubule inhibitor, has been approved to treat metastatic breast cancer in certain… (More)
Is this relevant?
2009
2009
Cr-mediated coupling reactions are usually achieved with a slight excess of a given nucleophile. To develop a cost-effective use… (More)
Is this relevant?
2009
2009
A practical method is reported to synthesize E7389 C27-C35 building block 13 from 1,2-O-isopropylidene-alpha-D-5-deoxyglucurono-6… (More)
  • figure 1
  • figure 2
Is this relevant?
2009
2009
With sequential use of catalytic asymmetric Cr-mediated coupling reactions, E7389 C14-C35 and halichondrin C14-C38 building… (More)
  • figure 1
Is this relevant?